Epigallocatechin Gallate(EGCG)Inhibited the Apoptosis in ALV-J-Infected DF-1 Cells by Inactivation of Nuclear Factor Κb Pathway

ZHANG Ying,YIN Hua-dong,WU Xiu-hong,YANG Hai-bin,ZHONG Ying-fu,YUAN Lin-ying,LI Zhong-lin,XU Ze
DOI: https://doi.org/10.16036/j.issn.1000-2650.2018.02.019
2018-01-01
Abstract:[Objective]To assess the antiviral effects of EGCG on ALV-J-induced cell apoptosis in vitro, and provide theoretical basis for the prevention and cure of ALV-J.[Method]DF-1 cells were treated with the EGCG concentrations of 0,5,10,20 and 40 μg/mL,respectively.Then,the cell activity,the env mRNA expression,ALV p27 antigen level,NF-κB activity,the protein expression of NF-κB p50 and p65 were examined at the 0,24,48,72 and 96 h after EGCG-treated.[Result]EGCG alleviated the ALV-J-induced apoptosis in a dose-dependent manner. High concentrations (20 and 40 μg/mL) inh-ibited the growth of DF-1 cell,and low concentration (5 μg/mL)did not suppress the ALV-J virus,so 10 μg/mL was the most appropriate concentration. After 96 h of incubation,10 μg/mL EGCG improved the ALV-J-triggered suppression of the nuclear transcription factor system by enhancing cytoplasmic NF-κB p50/p65 expression and inhibiting nuclear NF-κB p50/p65 expression,resulting in decreased cell apoptosis.[Conclusion]These results demonstrated that EGCG can increase the resistance ability to ALV-J in DF-1 cells with a dose-dependent manner via the NF-κB signaling pathway,and the optimum additive concentration was 10 μg/mL.
What problem does this paper attempt to address?